Cargando…
Multiomic Approaches to Uncover the Complexities of Dystrophin-Associated Cardiomyopathy
Despite major progress in treating skeletal muscle disease associated with dystrophinopathies, cardiomyopathy is emerging as a major cause of death in people carrying dystrophin gene mutations that remain without a targeted cure even with new treatment directions and advances in modelling abilities....
Autores principales: | Gowran, Aoife, Brioschi, Maura, Rovina, Davide, Chiesa, Mattia, Piacentini, Luca, Mallia, Sara, Banfi, Cristina, Pompilio, Giulio, Santoro, Rosaria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396646/ https://www.ncbi.nlm.nih.gov/pubmed/34445659 http://dx.doi.org/10.3390/ijms22168954 |
Ejemplares similares
-
“Betwixt Mine Eye and Heart a League Is Took”: The Progress of Induced Pluripotent Stem-Cell-Based Models of Dystrophin-Associated Cardiomyopathy
por: Rovina, Davide, et al.
Publicado: (2020) -
Dystrophin Cardiomyopathies: Clinical Management, Molecular Pathogenesis and Evolution towards Precision Medicine
por: D’Amario, Domenico, et al.
Publicado: (2018) -
The Endocannabinoid System and Cannabidiol: Past, Present, and Prospective for Cardiovascular Diseases
por: Rabino, Martina, et al.
Publicado: (2021) -
Unchain My Heart: Integrins at the Basis of iPSC Cardiomyocyte Differentiation
por: Santoro, Rosaria, et al.
Publicado: (2019) -
Calcium handling maturation and adaptation to increased substrate stiffness in human iPSC-derived cardiomyocytes: The impact of full-length dystrophin deficiency
por: Pioner, Josè Manuel, et al.
Publicado: (2022)